Display options
Share it on

Exp Clin Cardiol. 2003;8(1):10-2.

Relationship between basal nitric oxide and ventricular repolarization in an intact heart.

Experimental and clinical cardiology

Lexin Wang

Affiliations

  1. School of Biomedical Sciences, Charles Sturt University, Wagga Wagga, Australia.

PMID: 19644580 PMCID: PMC2716192

Abstract

Recent studies suggest that endogenous nitric oxide (NO) attenuates ischemia- or reperfusion-induced shortening in the action potential duration of ventricular myocytes. The effect of basal NO on ventricular repolarization in an intact heart remains unclear. The activation-recovery interval was measured from 32 epicardial electrocardiograms in six anesthetized, open-chest sheep. Intravenous administration of N(G)-nitro-L-arginine, a NO synthase inhibitor, increased left ventricular systolic pressure from 101+/-7 mmHg to 118+/-10 mmHg (P=0.02), and left ventricular end diastolic pressure from 6.3+/-1.5 mmHg to 8.8+/-1.8 mmHg (P<0.01) without changing the heart rate (96+/-4 beats/min versus 94+/-3 beats/min, P=0.06). The average activation-recovery interval from the 32 ventricular sites remained unchanged in each animal after the administration of N(G)-nitro-L-arginine (P>0.05). The pooled activation-recovery interval in the six animals before and 60 min after drug administration was 287+/-21 ms and 288+/-27 ms, respectively (P>0.05). It was concluded that basal NO is important in maintaining hemodynamics but has limited impact on ventricular repolarization.

Keywords: Activation-recovery interval; Cardiac electrophysiology; Nitric oxide; Ventricular repolarization

References

  1. Exp Clin Cardiol. 2001 Fall;6(3):167-71 - PubMed
  2. Chin J Physiol. 2000 Sep 30;43(3):113-7 - PubMed
  3. J Surg Res. 2000 Jul;92(1):56-63 - PubMed
  4. Pacing Clin Electrophysiol. 2000 Mar;23(3):359-64 - PubMed
  5. Circulation. 1997 Dec 2;96(11):4044-9 - PubMed
  6. Crit Care Med. 2000 Jun;28(6):1713-20 - PubMed
  7. Circulation. 1985 Dec;72(6):1372-9 - PubMed
  8. Circulation. 1990 Jan;81(1):281-8 - PubMed
  9. J Pharmacol Exp Ther. 2001 Aug;298(2):531-8 - PubMed
  10. J Mol Cell Cardiol. 2001 Feb;33(2):331-41 - PubMed
  11. Cardiovasc Res. 1995 Nov;30(5):788-98 - PubMed

Publication Types